Genetic Screening Before Carbamazepine Use Curbs Reactions

Dr. Chen’s study was funded by the National Science Council of Taiwan, the Taiwan Drug Relief Foundation, and the Academy-Industry Collaboration Program. Some of Dr. Chen’s associates reported ties to Pharmigene Inc., and some reported filing a patent for a risk assessment tool for adverse drug reactions. Dr. McCormack’s study was funded by the U.K. Department of Health, the Wellcome Trust, Brainwave–the Irish Epilepsy Association, and several other sources. Dr. McCormack’s associates reported ties to numerous industry sources.